Advarra leak
ent_c82ec81b21fa23bb89238f89
Disclosures
4
Leak Site · 1 jurisdiction
Incidents
1
filings grouped by incident
Max affected reported
—
no filed count in sample
Leak-site claims
4
unverified actor claims
Identity resolution
- Canonical name
- Advarra leak
- Normalized
- advarra leak— dedupe via name-norm; Microsoft / MSFT collapse to one row
- GLEIF LEI
- No match
- SEC EDGAR CIK
- None — not an SEC registrant
- Domain
- advarra.com
Unverified threat-actor claim — not a regulatory filing
Attribution, victim identity, and counts shown here derive from a threat actor's public extortion-blog claims, aggregated by ransomware.live. They have not been validated by the victim or any regulator. Treat them as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Disclosure history (4)newest first
- GLOBALLeak Siteas victim2023-11-05
Advarra provides innovative regulatory compliance solutions and expertise throughout the research lifecycle. Our integrated end-to-end compliance management platform combines site training, protocol compliance, and patient engagement, plus experienced consultants available to assist your team.
- GLOBALLeak Siteas victim2023-11-02
Advancing clinical research by enabling the research ecosystem to develop life-changing therapies.
- GLOBALLeak Siteas victim2023-11-01
.
- GLOBALLeak Siteas victim2023-10-31
Advarra advances the way clinical research is conducted: bringing life sciences companies, CROs, research sites, investigators, and academia together at the intersection of safety, technology, and collaboration. With trusted IRB and IBC review solutions, innovative technologies, experienced consultants, and deep-seated connections across the industry, Advarra provides integrated solutions that safeguard trial participants, empower clinical sites, ensure compliance, and optimize research performance. Advarra is advancing clinical trials to make them safer, smarter, and faster. For more information, visit advarra.com.